|
intercellular communication |
10 |
|
liver cancer |
10 |
|
neutralizing antibody |
10 |
|
proteomics |
10 |
|
tumor microenvironment |
10 |
|
drug repositioning |
7 |
|
ischemic heart disease |
7 |
|
lung cancer |
7 |
|
metabolic re-programming |
7 |
|
trimetazidine |
7 |
|
antibiotics resistance |
5 |
|
atrial fibrillation |
5 |
|
community |
5 |
|
direct oral anticoagulant |
5 |
|
education |
5 |
|
ischemic stroke |
5 |
|
knowledge |
5 |
|
nonadherence |
5 |
|
renal function variability |
5 |
|
warfarin |
5 |
|
bortezomib |
2 |
|
cell transplantation. |
2 |
|
olfactory nerve. |
2 |
|
proteasome inhibitors |
2 |
|
acquired hemophilia a |
1 |
|
acute lymphoblastic leukaemia |
1 |
|
acute lymphoblastic leukemia |
1 |
|
carfilzomib |
1 |
|
chinese |
1 |
|
diagnosis |
1 |
|
dna damage |
1 |
|
early t-cell precursor acute lymphoblastic leukemia |
1 |
|
etp-all |
1 |
|
hong kong |
1 |
|
ixazomib |
1 |
|
mitotic catastrophe |
1 |
|
molecular pathogenesis |
1 |
|
novel therapies |
1 |
|
retrospective review |
1 |
|
t lymphoblastic leukemia |
1 |
|
wee1 |
1 |
